{
  "event_id": "4f801de57f04",
  "ticker": "ADAP",
  "company_name": "Adaptimmune Therapeutics",
  "drug_name": "Afami-cel",
  "pdufa_date": "2024-08-04",
  "approval_type": {
    "status": "found",
    "value": "bla",
    "source": "websearch:SPEARHEAD-1 Phase 2 (single-arm)",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.071412",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "Synovial sarcoma",
    "source": "websearch:SPEARHEAD-1 Phase 2 (single-arm)",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.071413",
    "error": null
  },
  "generic_name": {
    "status": "found",
    "value": "afamitresgene autoleucel",
    "source": "websearch_fda",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:05:16.351049",
    "error": null
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Oncology",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:58.413959",
    "error": null
  },
  "phase": {
    "status": "found",
    "value": "Phase 3",
    "source": "websearch_clinical",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:05:16.351049",
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:SPEARHEAD-1 Phase 2 (single-arm)",
    "confidence": 0.85,
    "evidence": [
      "SPEARHEAD-1 Phase 2 (single-arm)"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.071399",
    "error": null
  },
  "p_value": {
    "status": "found",
    "value": "single-arm Phase 2, ORR 38.6%",
    "source": "websearch",
    "confidence": 0.85,
    "trial": "SPEARHEAD-1",
    "tier": 2,
    "note": "No numeric p-value applicable"
  },
  "p_value_numeric": null,
  "effect_size": {
    "status": "found",
    "value": "ORR 43.2% (95% CI 28.4-59.0)",
    "source": "websearch:SPEARHEAD-1 Phase 2 (single-arm)",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.071408",
    "error": null
  },
  "safety_signal": {
    "status": "found",
    "value": false,
    "source": "default_for_approved",
    "confidence": 0.9,
    "tier": 1,
    "note": "No blocking safety signals at approval"
  },
  "phase3_study_names": [
    "A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEARâ„¢ T Cells in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma"
  ],
  "nct_ids": [
    "NCT04044768"
  ],
  "enrollment": {
    "value": 52,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2
  },
  "has_prior_crl": {
    "status": "found",
    "value": false,
    "source": "derived_from_first_submission",
    "confidence": 0.95,
    "tier": 2
  },
  "prior_crl_reason": null,
  "is_resubmission": {
    "status": "found",
    "value": 0,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": true,
    "source": "derived_from_approval",
    "confidence": 0.95,
    "tier": 1,
    "note": "Approved drugs must have passed PAI"
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "inferred_from_approval",
    "confidence": 0.8,
    "tier": 2,
    "note": "Approved drugs unlikely to have blocking warning letters"
  },
  "result": "approved",
  "data_quality_score": 0.075,
  "collected_at": "2026-01-09T00:22:25.694937",
  "enriched_at": "2026-01-12T08:47:46.152786",
  "needs_manual_review": false,
  "review_reasons": [],
  "original_case_id": "d3fc02020ad4",
  "fda_designations": {
    "breakthrough_therapy": true,
    "fast_track": false,
    "priority_review": true,
    "orphan_drug": true,
    "accelerated_approval": true
  },
  "mechanism_of_action": "TCR-T cell therapy",
  "adcom_info": {
    "scheduled": false,
    "held": false,
    "outcome": null,
    "vote": null
  },
  "days_to_pdufa": -524,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:36.952624",
  "is_single_arm": {
    "value": true,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "interventionModel=SINGLE_GROUP",
      "allocation=NA"
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-11T08:28:05.382492",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "trial_region": {
    "value": "global",
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "countries=['SPAIN', 'FRANCE', 'UNITED KINGDOM', 'UNITED STATES', 'CANADA']..."
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-11T08:28:05.382524",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "adcom_scheduled": {
    "value": false,
    "status": "confirmed_none",
    "source": "websearch_adcom",
    "confidence": 0.7,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:31:59.508143"
  },
  "adcom_vote_ratio": {
    "value": null,
    "status": "not_applicable",
    "source": "websearch_adcom",
    "confidence": 0.6,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:31:59.508150"
  },
  "breakthrough_therapy": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:47:33.425021",
    "search_status": "CONFIRMED_NONE"
  },
  "orphan_drug": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:47:38.602050",
    "search_status": "CONFIRMED_NONE"
  },
  "priority_review": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "FDA Accepts BLA for Afami-Cel for Priority Review as ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:47:39.818077",
    "search_status": "FOUND"
  },
  "fast_track": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:47:45.082808",
    "search_status": "CONFIRMED_NONE"
  },
  "accelerated_approval": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "FDA Approves First Engineered Cell Therapy for a Solid Tumor"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:47:46.152173",
    "search_status": "FOUND"
  }
}